SBIR Phase I: Development of a nasal compression device with medicated intranasal sponges for the treatment of nosebleeds in any setting

这个小企业创新研究（SBIR）第一阶段项目是帮助治疗常见的鼻出血。流鼻血是一个常见的问题，60%的人的经验。拟议的项目开发了一种有效和低成本的创新技术，通过将外部压力与鼻内药物相结合来解决这个问题，当任何用户以标称方式放置时。该解决方案将提供一种简单的方法，减少患者访问医疗保健服务的需要，并减轻医疗保健提供者治疗鼻出血的负担。该项目的目标是设计和开发一种有效的鼻出血治疗装置，用于儿童和成人，使用原型鼻夹与鼻内药物海绵结合外部压力。本项目的目标包括完成系统研究，以（1）设计和开发鼻夹，鼻夹带有预先给药的鼻内海绵，当以标称方式放置时，能够持续施加适当的压力并洗脱适当的药物量，（2）使用鼻出血模型测试器械，（3）确定制造工艺，以成本有效的方式将装置商业化和规模化。该奖项反映了NSF的法定使命，并被认为值得通过使用基金会的智力价值和更广泛的影响审查标准进行评估来支持。

This Small Business Innovation Research (SBIR) Phase I project is to help treat the common nosebleed. Nosebleeds are a common problem that 60% of people experience. The proposed project develops an effective and low-cost innovative technology to address this by combining external pressure with intranasal medication when placed in a nominal manner by any user. The solution would provide a simple method that reduces the need for patients to visit health care services, and reduces the burden of health care providers for treating nosebleeds. The goal of this project is to design and develop an effective nosebleed treatment device for children and adults that combines external pressure using a prototype nasal clip with intranasal medication sponges. The objectives of this project include completing systematic studies towards (1) design and development of a nasal clip with pre-medicated intranasal sponges capable of consistently applying the proper amount of pressure and eluting the proper amount of medication when placed in a nominal manner, (2) testing of the device using a nosebleed model, (3) identifying manufacturing processes to commercialize and scale the device in a cost effective manner. The outcome will be a functional and lab tested nosebleed treatment clip.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.